TY - JOUR
T1 - The International Association for the Study of Lung Cancer Staging Project for Lung Cancer
T2 - Proposals for the Revision of the M Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer
AU - Members of the International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee, Members of the Advisory Boards, and Participating Institutions of the Lung Cancer Domain
AU - Fong, Kwun M.
AU - Rosenthal, Adam
AU - Giroux, Dorothy J.
AU - Nishimura, Katherine K.
AU - Erasmus, Jeremy
AU - Lievens, Yolande
AU - Marino, Mirella
AU - Marom, Edith M.
AU - Putora, Paul Martin
AU - Singh, Navneet
AU - Suárez, Francisco
AU - Rami-Porta, Ramon
AU - Detterbeck, Frank
AU - Eberhardt, Wilfried E.E.
AU - Asamura, Hisao
N1 - Publisher Copyright:
© 2024 International Association for the Study of Lung Cancer
PY - 2024/5
Y1 - 2024/5
N2 - Introduction: This study analyzed all metastatic categories of the current TNM classification of NSCLC to propose modifications of the M component in the next edition (ninth) of the classification. Methods: A database of 124,581 patients diagnosed between 2011 and 2019 was established; of these, 14,937 with NSCLC in stages IVA to IVB were available for this analysis. Overall survival was calculated using the Kaplan-Meier method, and prognosis was assessed using multivariable-adjusted Cox proportional hazards regression. Results: The eighth edition M categories revealed good discrimination in the ninth edition data set. Assessments revealed that an increasing number of metastatic lesions were associated with decreasing prognosis; because this seems to be a continuum and adjustment for confounders was not possible, no specific lesion number was deemed appropriate for stage classification. Among tumors involving multiple metastases, decreasing prognosis was found with an increasing number of organ systems involved. Multiple assessments, including after adjustment for potential confounders, revealed that M1c patients who had metastases to a single extrathoracic organ system were prognostically distinct from M1c patients who had involvement of multiple extrathoracic organ systems. Conclusions: These data validate the eighth edition M1a and M1b categories, which are recommended to be maintained. We propose the M1c category be divided into M1c1 (involvement of a single extrathoracic organ system) and M1c2 (involvement of multiple extrathoracic organ systems).
AB - Introduction: This study analyzed all metastatic categories of the current TNM classification of NSCLC to propose modifications of the M component in the next edition (ninth) of the classification. Methods: A database of 124,581 patients diagnosed between 2011 and 2019 was established; of these, 14,937 with NSCLC in stages IVA to IVB were available for this analysis. Overall survival was calculated using the Kaplan-Meier method, and prognosis was assessed using multivariable-adjusted Cox proportional hazards regression. Results: The eighth edition M categories revealed good discrimination in the ninth edition data set. Assessments revealed that an increasing number of metastatic lesions were associated with decreasing prognosis; because this seems to be a continuum and adjustment for confounders was not possible, no specific lesion number was deemed appropriate for stage classification. Among tumors involving multiple metastases, decreasing prognosis was found with an increasing number of organ systems involved. Multiple assessments, including after adjustment for potential confounders, revealed that M1c patients who had metastases to a single extrathoracic organ system were prognostically distinct from M1c patients who had involvement of multiple extrathoracic organ systems. Conclusions: These data validate the eighth edition M1a and M1b categories, which are recommended to be maintained. We propose the M1c category be divided into M1c1 (involvement of a single extrathoracic organ system) and M1c2 (involvement of multiple extrathoracic organ systems).
KW - Lung cancer
KW - Metastases
KW - Non–small cell lung cancer
KW - Stage IV lung cancer
KW - Stage classification
UR - http://www.scopus.com/inward/record.url?scp=85190391894&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85190391894&partnerID=8YFLogxK
U2 - 10.1016/j.jtho.2024.01.019
DO - 10.1016/j.jtho.2024.01.019
M3 - Article
C2 - 38320664
AN - SCOPUS:85190391894
SN - 1556-0864
VL - 19
SP - 786
EP - 802
JO - Journal of Thoracic Oncology
JF - Journal of Thoracic Oncology
IS - 5
ER -